FDA Seeks Public Comments on PMI Application to Market IQOS 3 as Modified Risk Tobacco Product

NEW YORK–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) today opened a public comment period on Philip Morris International’s (PMI–NYSE: PM) application seeking authorization to market the IQOS 3 electrically heated tobacco system as a Modified Risk Tobacco Product (MRTP). PMI’s application requests the same reduced exposure modification orders granted on July 7, 2020, for the IQOS 2.4 system—the first, and only, electronic nicotine product to be granted marketing orders through Read more